Recombinant human CD40 ligand

CD40 ligand · National Institute of Allergy and Infectious Diseases (NIAID)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Recombinant human CD40 ligand, covering 2008-03-04 to 2008-03-04. Get the full timeline:

Most recent: Clinical Trial Update: Study of Immune Responses and Safety of Recombinant Human CD40 Ligand in Patients With X-Linked Hyper-IgM Syndrome [Phase 2]

See pricing